Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -33.33% | -33.33% | -27.27% |
29/03 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
19/03 | RAMM Pharma Corp. cancelled the transaction announced on September 5, 2023 | CI |
Sales 2022 | 3.9M 2.85M 238M | Sales 2023 | 5.07M 3.71M 309M | Capitalization | 5.97M 4.37M 364M |
---|---|---|---|---|---|
Net income 2022 | -21M -15.37M -1.28B | Net income 2023 | -7M -5.12M -427M | EV / Sales 2022 | 3.95 x |
Net cash position 2022 | 9.09M 6.65M 554M | Net cash position 2023 | 4.71M 3.45M 287M | EV / Sales 2023 | 0.25 x |
P/E ratio 2022 |
-1.17
x | P/E ratio 2023 |
-0.78
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.72% |
1 day | -33.33% | ||
1 week | -33.33% | ||
Current month | -33.33% | ||
1 month | -38.46% | ||
3 months | -11.11% | ||
6 months | -42.86% | ||
Current year | -27.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/19/01 |
José Roldan
DFI | Director of Finance/CFO | - | 09/22/09 |
Edelma Ros
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Klein
BRD | Director/Board Member | 64 | 01/19/01 |
Daniel Augereau
BRD | Director/Board Member | 80 | 01/19/01 |
Jackie Burnett
CEO | Chief Executive Officer | - | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 0.04 | -33.33% | 50,000 |
Delayed Quote Canadian Securities Exchange, May 03, 2024 at 12:08 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-27.27% | 5.21M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- RAMM Stock